Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol[S]

A low level of high density lipoprotein cholesterol (HDL-C) is a powerful risk factor for cardiovascular disease. However, despite the reported key role of apolipo-proteins, specifically, apoA-I, in HDL metabolism, lipid molecular composition of HDL particles in subjects with high and low HDL-C levels is currently unknown. Here lipidomics was used to study HDL derived from well-characterized high and low HDL-C subjects. Low HDL-C subjects had elevated triacylglycerols and diminished lysophosphatidylcholines and sphingomyelins. Using information about the lipid composition of HDL particles in these two groups, we reconstituted HDL particles in silico by performing large-scale molecular dynamics simulations. In addition to confirming the measured change in particle size, we found that the changes in lipid composition also induced specific spatial distributions of lipids within the HDL particles, including a higher amount of triacylglycerols at the surface of HDL particles in low HDL-C subjects. Our findings have important implications for understanding HDL metabolism and function. For the first time we demonstrate the power of combining molecular profiling of lipoproteins with dynamic modeling of lipoprotein structure.

[1]  P. Whincup,et al.  HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. , 2009, Atherosclerosis.

[2]  P. Barter,et al.  Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[3]  M. Taskinen,et al.  Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations , 2009, Diabetologia.

[4]  Matej Oresic,et al.  Lipidomics: a new window to biomedical frontiers. , 2008, Trends in biotechnology.

[5]  J. Kumpula,et al.  Reconsideration of hydrophobic lipid distributions in lipoprotein particles. , 2008, Chemistry and physics of lipids.

[6]  G. Watts,et al.  HDL metabolism in context: looking on the bright side , 2008, Current opinion in lipidology.

[7]  J. Heinecke,et al.  The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses. , 2008, Biochemistry.

[8]  R. Larson,et al.  The MARTINI Coarse-Grained Force Field: Extension to Proteins. , 2008, Journal of chemical theory and computation.

[9]  Perttu S. Niemelä,et al.  Structure of spheroidal HDL particles revealed by combined atomistic and coarse-grained simulations. , 2008, Biophysical journal.

[10]  D. van der Spoel,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[11]  J. Kastelein,et al.  High-density lipoprotein: A fall from grace? , 2008, Annals of medicine.

[12]  D. Tieleman,et al.  The MARTINI force field: coarse grained model for biomolecular simulations. , 2007, The journal of physical chemistry. B.

[13]  Sina A. Gharib,et al.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.

[14]  Marko Sysi-Aho,et al.  Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects – A Monozygotic Twin Study , 2007, PloS one.

[15]  D. Rader Molecular regulation of HDL metabolism and function: implications for novel therapies. , 2006, The Journal of clinical investigation.

[16]  P. Subbaiah,et al.  Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate. , 2006, Biochemistry.

[17]  M. Taskinen,et al.  Decreased High-Density Lipoprotein (HDL) Particle Size, Pre&bgr;-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[18]  M. Jauhiainen,et al.  Determination of human plasma phospholipid transfer protein mass and activity. , 2005, Methods.

[19]  Xianlin Han,et al.  Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. , 2005, Mass spectrometry reviews.

[20]  C. Fielding,et al.  Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. , 2004, Biochemistry.

[21]  R. Murphy,et al.  Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids , 2004, Journal of the American Society for Mass Spectrometry.

[22]  A. Tall,et al.  ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Brewer,et al.  Increasing HDL Cholesterol Levels. , 2004, The New England journal of medicine.

[24]  M. Jauhiainen,et al.  Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA Published, JLR Papers in Press, November 16, 2003. DOI 10.1194/jlr.D300023-JLR200 , 2004, Journal of Lipid Research.

[25]  M. Jauhiainen,et al.  PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma Published, JLR Papers in Press, June 16, 2003. DOI 10.1194/jlr.M300059-JLR200 , 2003, Journal of Lipid Research.

[26]  I. Jolliffe,et al.  Principal Component Analysis , 2003, Encyclopedia of Machine Learning.

[27]  M. Phillips,et al.  High density lipoprotein structure. , 2003, Frontiers in bioscience : a journal and virtual library.

[28]  M. Barker,et al.  Partial least squares for discrimination , 2003 .

[29]  A. Colell,et al.  Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. , 2003, The Journal of clinical investigation.

[30]  R. Maeba,et al.  Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers Published, JLR Papers in Press, October 16, 2002. DOI 10.1194/jlr.M200340-JLR200 , 2003, Journal of Lipid Research.

[31]  D. Vance,et al.  Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .

[32]  P. Barter,et al.  Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. , 2002, Atherosclerosis. Supplements.

[33]  Y. Marcel,et al.  Heteronuclear NMR studies of human serum apolipoprotein A‐I , 2002, FEBS letters.

[34]  J. Viikari,et al.  LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. , 2002, Journal of lipid research.

[35]  M. Jauhiainen,et al.  Dietary determinants of serum paraoxonase activity in healthy humans. , 2002, Atherosclerosis.

[36]  R. Murphy Free-radical-induced oxidation of arachidonoyl plasmalogen phospholipids: antioxidant mechanism and precursor pathway for bioactive eicosanoids. , 2001, Chemical research in toxicology.

[37]  M. Jauhiainen,et al.  The impact of phospholipid transfer protein (PLTP) on HDL metabolism. , 2001, Atherosclerosis.

[38]  A. Jonas,et al.  Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. , 2001, Journal of lipid research.

[39]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[40]  W. J. Johnson,et al.  High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI* , 2000, The Journal of Biological Chemistry.

[41]  K. Rye,et al.  The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. , 2000, Biochemistry.

[42]  Anthony E. Klon,et al.  A Detailed Molecular Belt Model for Apolipoprotein A-I in Discoidal High Density Lipoprotein* , 1999, The Journal of Biological Chemistry.

[43]  H. Brewer,et al.  Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[45]  A. Chapelle,et al.  The intrinsic factor–vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein , 1999, Nature Medicine.

[46]  G. Lewis,et al.  Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. , 1999, The Journal of clinical investigation.

[47]  A. Tall,et al.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. , 1999, The Journal of clinical investigation.

[48]  J. Gamble,et al.  Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Parks,et al.  The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation* , 1998, The Journal of Biological Chemistry.

[50]  P. Barter,et al.  Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. , 1998, Journal of lipid research.

[51]  J. Engler,et al.  Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Paul,et al.  HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[53]  H. Brewer,et al.  Plasma Phospholipid Transfer Protein , 1997, The Journal of Biological Chemistry.

[54]  J. Breslow,et al.  Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Tall,et al.  Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. , 1996, The Journal of clinical investigation.

[56]  A. Jonas,et al.  Sphingomyelin Inhibits the Lecithin-Cholesterol Acyltransferase Reaction with Reconstituted High Density Lipoproteins by Decreasing Enzyme Binding* , 1996, The Journal of Biological Chemistry.

[57]  W. J. Johnson,et al.  The Effect of High Density Lipoprotein Phospholipid Acyl Chain Composition on the Efflux of Cellular Free Cholesterol (*) , 1995, The Journal of Biological Chemistry.

[58]  M. Krönke,et al.  TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdown , 1992, Cell.

[59]  N. Maeda,et al.  Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Ibdah,et al.  Effects of lipid composition and packing on the adsorption of apolipoprotein A-I to lipid monolayers. , 1988, Biochemistry.

[61]  M. Taskinen,et al.  Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes , 1988, Arteriosclerosis.

[62]  J. Groener,et al.  Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. , 1986, Clinical chemistry.

[63]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[64]  G. Scherphof,et al.  Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. , 1982, Biochimica et biophysica acta.

[65]  E. Gong,et al.  Characterization of human high-density lipoproteins by gradient gel electrophoresis. , 1981, Biochimica et biophysica acta.

[66]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[67]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[68]  Seppo Koskinen,et al.  HEALTH AND FUNCTIONAL CAPACITY IN FINLAND Baseline Results of the Health 2000 Health Examination Survey , 2004 .

[69]  C. Couillard,et al.  A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma. , 2001, Journal of lipid research.

[70]  B. Kowalski,et al.  Partial least-squares regression: a tutorial , 1986 .

[71]  W. H. Heaton,et al.  Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. , 1982, Arteriosclerosis.